Citations

Clear

426 citation(s) found for "ST, Reza".

Do optic neuritis patients report their visual impairment more frequently upon awakening?
Eslami, Mohammad‐Javad , Etemadifar, Masoud , Khalili, Mohammad Reza , Faraidan-Esfahani, Mahboobeh, Jahanbani‐Ardakani, Hamidreza , Ghorbani, Sara, Ghorbani, Sarah , Abtahi, Seyed-Hossein

Mayo Clinic

International Journal of Neuroscience | February 23, 2021 | Volume: 132 | Issue: 12 | Pages: 1261-1263

10.1080/00207454.2021.1879062 | PMID 33618604 Get It

NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021
Altman, Jessica K. , Assi, Rita, Bachiashvili, Kimo, Fathi, Amir T. , Fedorov, Kateryna, Foran, James M. , Gojo, Ivana , Goldberg, Aaron, Hall, Aric C. , Jonas, Brian A., Levine, Matthew R., Mangan, James, Mannis, Gabriel N. , Marcucci, Guido , Moriarty, Kelsey, Ali, Moaath Mustafa, Neff, Jadee , Nejati, Reza , Olin, Rebecca L. , Patel, Anand, Percival, Mary‐Elizabeth M. , Perl, Alexander E. , Pettit, Kristen, Rao, Dinesh S. , Ravandi‐Kashani, Farhad, Schwabkey, Zaker, Shallis, Rory, Stahl, Maximilian, Stone, Richard M. , Thota, Swapna, Uy, Geoffrey L., Walker, Alison, Wang, Eunice, Awotiwon, Ajibola, Roth, Sydney L., Stehman, Katie, Strickland, Stephen A. , Przespolewski, Amanda , Strickland, Stephen Anthony , Pollyea, Daniel Aaron , Assi, Rita, Bachiashvili, Kimo, Bhatt, Vijaya Raj , Fedorov, Kateryna, Goldberg, Aaron, Jonas, Brian A., Levine, Matthew R., Mangan, James, Mims, Alice S , Moriarty, Kelsey, Ali, Moaath Mustafa, Patel, Anand, Pettit, Kristen, Schwabkey, Zaker, Shallis, Rory, Stahl, Maximilian, Thota, Swapna, Uy, Geoffrey L., Walker, Alison, Wang, Eunice, Awotiwon, Ajibola, Roth, Sydney L., Stehman, Katie

Mayo Clinic

Journal of the National Comprehensive Cancer Network | January 6, 2021 | Volume: 19 | Issue: 1 | Pages: 16-27

10.6004/jnccn.2021.0002 | PMID 33406488 Get It

The NCCN Guidelines for Acute Myeloid Leukemia (AML) provide recommendations for the diagnosis and treatment of adults with AML based on clinical trials that have led to significant improvements in treatment, or have yielded new information regarding factors with prognostic importance, and are intended to aid physicians with clinical decision-making. These NCCN Guidelines Insights focus on recent select updates to the NCCN Guidelines, including familial genetic alterations in AML, postinduction or postremission treatment strategies in low-risk acute promyelocytic leukemia or favorable-risk AML, principles surrounding the use of venetoclax-based therapies, and considerations for patients who prefer not to receive blood transfusions during treatment.
New Horizons in Hydrogels for Methotrexate Delivery
Dehshahri, Ali , Kumar, Anuj , Madamsetty, Vijay Sagar , Uzielienè, Ilona , Tavakol, Shima , Azedi, Fereshteh , Fekri, Hojjat Samareh, Zarrabi, Ali , Mohammadinejad, Reza , Thakur, Vijay Kumar , Madamsetty, Vijay S , Tavakol, Shima , Dehshahri, Ali

Mayo Clinic

Gels | December 30, 2020 | Volume: 7 | Issue: 1 | Pages: 2

10.3390/gels7010002 | PMID 33396629 Get It

Since its first clinical application, methotrexate (MTX) has been widely used for the treatment of human diseases. Despite great advantages, some properties such as poor absorption, short plasma half-life and unpredictable bioavailability have led researchers to seek novel delivery systems to improve its characteristics for parenteral and oral administration. Recently, great attention has been directed to hydrogels for the preparation of MTX formulations. This review describes the potential of hydrogels for the formulation of MTX to treat cancer, rheumatoid arthritis, psoriasis and central nervous system diseases. We will delineate the state-of-the-art and promising potential of hydrogels for systemic MTX delivery as well as transdermal delivery of the drug-using hydrogel-based formulations.
Consensus Statement for Pharmacological Management of Coronavirus Disease 2019 (COVID-19): A Pragmatic Approach
Javeri, Yash , Ak, Khanna, AA, Tayar, BG, Jagiasi, JLP, Portilla, Zirpe, Kapil , Ka, Popugaev, MLNG, Malbrain, Ma, Kirkman, MTV, Chan, Mer, M, Harriss, Mohammed, Rangappa, Pradeep, Piacevoli, Q, Mani, RK, Rc, Mishra, Bagdia, S, Donovan, Suzanne, ST, Reza, TY, Yeh, Videtta, Walter , R, Jain, Nasa, Prashant , Kashyap, Rahul , Bhaskar, Balu , Jagiasi, Bharat G , Juneja, Deven , Lipman, Jeffrey , J, Ng, Hashmi, Madiha , Türkoğlu, Melda , M, Singer, Garg, Rakesh Kumar , Yadav, Rakesh Kumar , TY, Yeh

Mayo Clinic

Asploro Journal of Biomedical and Clinical Case Reports | December 28, 2020 | Volume: 3 | Issue: 3 | Pages: 241-256

10.36502/2020/asjbccr.6219 Get It

Introduction: In the absence of high-quality evidence for Coronavirus disease-2019 (COVID-19), supportive care is advocated during this pandemic. We aim to develop a consensus statement from global experts for pharmacological management, based on the pathophysiology of COVID-19. Material and Methods: We used a modified Delphi methodology in three steps: 1) Formulation of the steering committee and questionnaire; 2) Delphi methodology and selection of experts; 3) Final meeting of the steering committee and analysis, discussion, preparation, and presentation of captured data. Results: 34 (73·9%) experts accepted the invitation for the study. We conducted two rounds of Delphi and consensus (>70% votes) was achieved on 11 out of 24 statements after the end of round two. Conclusion: This global consensus suggests that “Anti-viral therapy should be administered in the early infection phase of COVID-19 followed by low dose steroid therapy in pulmonary phase. Prophylactic dose anticoagulation should be used in hospitalized, mild to moderate COVID-19 patients. We make no suggestions for the use of immune modulation therapy”.
Anti‐inflammatory effect of amitriptyline in a rat model of acetic acid‐induced colitis: the involvement of the TLR4/NF‐kB signaling pathway
Dejban, Pegah, Sahraei, Masomeh, Chamanara, Mohsen , Dehpour, Ahmad Reza , Rashidian, Amir , Dehpour, Ahmad Reza

Mayo Clinic

Fundamental & Clinical Pharmacology | December 18, 2020 | Volume: 35 | Issue: 5 | Pages: 843-851

10.1111/fcp.12642 | PMID 33336463 Get It

ABSTRACTInflammatory bowel disease (IBD) consists of ulcerative colitis and Crohn's disease, which affects gastrointestinal tract. The immune‐mediated inflammation is mostly considered as the pathogenesis of IBD. It has been demonstrated that amitriptyline exerts anti‐inflammatory influence; therefore, the aim of the current experiment is to evaluate the anti‐inflammatory impact of amitriptyline on intestinal disorders following acetic acid‐induced colitis in rats. Thirty male Wistar rats were randomly divided into five groups, including sham, control, dexamethasone (2 mg/kg), and amitriptyline (10 and 20 mg/kg). Intrarectal administration of acetic acid was applied to colitis induction in all study groups except for sham group. Animals were treated by oral administration of dexamethasone or amitriptyline. While macroscopic and microscopic lesions appeared after colitis induction treatment with dexamethasone and amitriptyline 10 and 20 mg/kg significantly improved lesions. Moreover, Toll‐like receptor 4 (TLR4) and nuclear factor binding kappa light‐chain (NF‐ĸB expression), tumor necrosis factor‐alpha (TNF‐α) level, and myeloperoxidase (MPO) activity were increased after colitis induction, whereas treatment with dexamethasone (2 mg/kg) or amitriptyline (10 and 20 mg/kg) caused a noticeable decrease in the TLR4 and pNF‐ĸB expression, TNF‐α level, and MPO activity. In conclusion, amitriptyline plays an anti‐inflammatory role through the suppression of TLR4/pNF‐ĸB signaling pathway in the rat model of acute colitis.
A Multicenter Survey on the Trend of Chest CT Scan Utilization: Tracing the First Footsteps of COVID-19 in Iran
Radmard, Amir Reza , Gholamrezanezhad, Ali , Montazeri, Seyed Ali , Kasaeian, Amir , Nematollahy, Nemat, Langrudi, Roghieh Molaee, Rashid, Reza Javad, Dehghan, Alireza , Hekmatnia, Ali , Shakourirad, Ali , Rad, Masoud Pezeshki, Moghadam, Reza Nafisi , Sharifian, Hashem , Enhesari, Ahmad , Aalinezhad, Marzieh , Soufi, Ghazaleh Jamalipour , Shakibafard, Alireza , Mohammadzadeh, Maryam , Jalli, Reza , Dehghan, Pooneh , Hashemi, Hassan , Sanei Taheri, Morteza , Radmard, Amir Reza , Montazeri, S Ali , Rad, Masoud Pezeshki , Karam, Mehrdad Bakhshayesh , Langroudi, Taraneh Faghihi , Raoufi, Masoomeh , Abrishami, Alireza , Bahrami‐Motlagh, Hooman

Mayo Clinic

Archives of Iranian Medicine | November 11, 2020 | Volume: 23 | Issue: 11 | Pages: 787-793

10.34172/aim.2020.105 | PMID 33220698 Get It

Background: Chest computed tomography (CT) scan has been used widely to diagnose COVID-19 in Iran. Objectives: To trace the footsteps of COVID-19 in Iran by exploring the trend in using chest CT scans and its economic impact on radiology departments. Methods: In this cross-sectional study, the number of imaging examinations from 33 tertiary radiology departments in 9 large cities of Iran was collected from September 23, 2019 to March 20, 2020 (Months 1 to 6) and the corresponding months in 2018–2019. Results: A 50.2% increase was noted in the chest CT scan utilization in 2019–2020 compared to 2018–2019. This increase was +15%, +15%, +27%, +2%, +1% in Months 1–5 of 2019–2020, respectively. In Month 6 of 2019–2020, a 251% increase in the acquisition of chest CT scans was observed compared to the Month 6 of 2018–2019. Following negative balance of revenue from Month 1 to 5 with respect to the inflation rate, the total income in Month 6 was further 1.5% less than the same Month in 2018–19. Conclusion: The observed peak in chest CT utilization in Month 3 prior to the surge in Month 6 could be explained by the seasonal influenza. However, unawareness about an emerging viral disease, i.e. COVID-19, might have underutilized chest CT in Months 4 and 5 before the official announcement in Month 6. The unbalanced increase in the workload of radiology departments in the shortage of cardiothoracic radiologists with the simultaneous decrease in income initiated a vicious cycle that worsened the economic repercussions of the pandemic.
Comparison of echocardiographic parameters with cardiac magnetic resonance imaging in the assessment of right ventricular function
Agasthi, Pradyumna , Siegel, Robert J. , Pujari, Sai Harika , Mookadam, Farouk , Venepally, Nithin R. , Wang, Panwen , Marcotte, François , Semkiv, Oksana I., Fath, Ayman R. , Jokerst, Clinton, Arsanjani, Reza , Ashraf, Hasan , Allam, Mohamed N A, Arsanjani, Reza , Chao, Chieh‐Ju , Mookadam, Farouk , Ashraf, Hasan, Brown, Lisa, Allam, Mohamed

Mayo Clinic

Echocardiography | October 4, 2020 | Volume: 37 | Issue: 11 | Pages: 1792-1802

10.1111/echo.14877 | PMID 33012034 Get It

AbstractIntroductionThe right ventricle (RV) strain measured by speckle tracking (RVS) is an echocardiographic parameter used to assess RV function. We compared RVS to RV fractional area change (FAC%), tricuspid annular plane systolic excursion (TAPSE) and Doppler tissue imaging‐derived peak systolic velocity (Sʹ) in the assessment of right ventricular (RV) systolic function measured using cardiac magnetic resonance imaging (MRI).MethodsWe enrolled consecutive patients who underwent cardiac MRI between Jan 2012 and Dec 2017 and a transthoracic echocardiogram (TTE) within 1 month of the MRI with no interval event. Baseline clinical characteristics and MRI parameters were extracted from chart review. Echocardiographic parameters were measured prospectively. TTE parameters including RVS, TAPSE, Sʹ, and FAC% were tested for accuracy to identify impaired RV EF (EF < 45% & <30%) using receiver operator curves.ResultsThe study cohort included 500 patients with mean age 55 years ± 18 and peak tricuspid regurgitation velocity 2.7 ± 1.4 m/s. The area under ROC for RVS was 0.69 (95% CI 0.63–0.75) and 0.78 (95% CI 0.70–0.88) to predict RVEF < 45% & RVEF < 30%, respectively. The RV FAC% had second highest accuracy of predicting RVEF among all the TTE parameters tested in study.ConclusionRight ventricular strain is the most accurate echocardiographic method to detect impaired right ventricular systolic function when using MRI as the gold standard.
The role of medicinal products in the treatment of inflammatory bowel diseases (IBD) through inhibition of TLR4/NF‐kappaB pathway
Dejban, Pegah, Nikravangolsefid, Nasrin , Chamanara, Mohsen , Dehpour, Ahmad Reza , Rashidian, Amir , Dehpour, Ahmad Reza

Mayo Clinic

Phytotherapy Research | September 25, 2020 | Volume: 35 | Issue: 2 | Pages: 835-845

10.1002/ptr.6866 | PMID 32929778 Get It

Inflammatory bowel disease (IBD) is a lifelong and recurrent disease of the gastrointestinal tract that afflicts many people in the world. Growing evidence has currently indicated that dysfunction of immune system, particularly toll‐like receptors 4 (TLR4) signaling pathway dysfunction plays a pivotal part in the pathogenesis of IBD. TLR4 signaling is involved both in the pathogenesis and in the efficacy of treatment of IBD. There are some medicinal products and herbal medicines, which their role in the treatment of IBD through modulation of TLR4 signaling has been implicated. The purpose of this review article is to summarize those medicinal products and herbal medicines.
A Unique Compensatory Mechanism for Total Pulmonary Vein Occlusion Post Atrial Fibrillation Catheter Ablation Visualized by Multimodality Imaging
Fath, Ayman R. , Aglan, Amro , Scott, Luis R. , Jokerst, Clinton, Narayanasamy, Hemalatha , Mookadam, Farouk , Mihyawi, Nawfal, Venepally, Nithin R. , Konduru, Sudheer, Arsanjani, Reza , Arsanjani, Reza

Mayo Clinic

Case Reports in Cardiology | September 24, 2020 | Volume: 2020 | Issue: No issue available | Pages: 1-4

10.1155/2020/9673958 | PMID 33029433 Get It

Pulmonary vein (PV) stenosis is a rare and serious complication of radiofrequency catheter ablation (RFCA) for atrial fibrillation. However, it can be asymptomatic or mildly symptomatic depending on the severity of the stenosis and the development of compensatory mechanisms. This study provides a detailed description and visualization of a unique type of venous collaterals that bypass the PV stenosis and drain directly in the left atrium alleviating PV stenosis sequelae. This study reports a case of a 61-year-old male who presented with mild dyspnea and fatigue 3 years post atrial fibrillation RFCA. After a thorough evaluation of the case, a redo-ablation was planned. As a part of the preablation workup, a transesophageal echocardiography (TEE), a ventilation-perfusion (V/Q) scan of the lungs, and a chest computed tomography angiogram (CTA) were performed. The TEE revealed total obstruction of the left superior PV, with no color Doppler flow detected. It also showed evidence of multiple collateral flows at the os of the left superior PV. The V/Q scan showed a large perfusion defect involving the entire left upper lobe consistent with a compromised left upper PV flow. The CTA with 3D volume rendering revealed the total occlusion of the left superior PV at its ostium. Moreover, the scan confirmed the pulmonary venous drainage via small collateral channels that was suggested by the TEE.
Methylated DNA Markers of Esophageal Squamous Cancer and Dysplasia: An International Study
Qin, Yi , Bamlet, William R. , Ravindran, Adharsh, Buglioni, Alessia , Cao, Xiaoming , Albert, Paul S. , Kim, Sungduk , Etemadi, Arash , Sotoudeh, Masoud , Smyrk, Thomas C. , Katzka, David A. , Topazian, Mark , Ahlquist, David A. , Iyer, Prasad G. , Bamlet, William R , Foote, Patrick H. , Slettedahl, Seth W , Mahoney, Douglas W. , Malekzadeh, Reza , Abnet, Christian C , Katzka, D A , Topazian, Mark D , Dawsey, Sanford M. , Ahlquist, David, Kisiel, John B , Qin, Y , Taylor, William R. , Slettedahl, Seth W. , Hu, Nan , Taylor, Philip R. , Malekzadeh, Reza , Abnet, Christian C. , Kisiel, John B.

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | September 18, 2020 | Volume: 29 | Issue: 12 | Pages: 2642-2650

10.1158/1055-9965.epi-20-0616 | PMID 32948633 Get It

Abstract Background: Discovery of methylated DNA markers (MDM) of esophageal squamous cell carcinoma (ESCC) has sparked interest in assessing these markers in tissue. We evaluated MDMs in ESCC from three geographically and ethnically distinct populations, and explored the feasibility of assaying MDMs from DNA obtained by swallowed balloon devices. Methods: MDMs were assayed in ESCC and normal tissues obtained from the populations of United States, Iran, and China, and from exfoliative cytology specimens obtained by balloons in a Chinese population. Areas under the receiver operating curve (AUC) of MDMs discriminating ESCC from normal tissues were calculated. Random forest prediction models were built, trained on U.S. cases and controls, and calibrated to U.S.-only controls (model 1) and three-country controls (model 2). Statistical tests were used to assess the relationship between dysplasia and MDM levels in balloons. Results: Extracted DNA from 333 ESCC and 322 normal tissues was analyzed, in addition to archival DNA from 98 balloons. For ESCC, model 1 validated in Iranian and Chinese tissues with AUCs of 0.90 and 0.87, and model 2 yielded AUCs of 0.99, 0.96, and 0.94 in tissues from the United States, Iran, and China, respectively. In Chinese balloons, MDMs showed a statistically significant trend of increasing levels with increasing grades of dysplasia (P &lt; 0.004). Conclusions: MDMs accurately discriminate ESCC from normal esophagus in tissues obtained from high- and low-incidence countries. Preliminary data suggest that levels of MDMs assayed in DNA from swallowed balloon devices increase with dysplasia grade. Larger studies are needed to validate these results. Impact: MDMs coupled with minimally invasive collection methods have the potential for worldwide application in ESCC screening.